HSP90AB1 and glioblastoma: In addition, a diverse range of nature-derived Hsp90 inhibitors is also discussed, which are pharmacologically active in both GBM and neurodegeneration, and could be used as potential leads for designing and developing potent Hsp90 inhibitors.